Nelfinavir Inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly

BACKGROUND: Antiviral therapies that target herpesviruses are clinically important. Nelfinavir is a protease inhibitor that targets the human immunodeficiency virus (HIV) infections aspartyl protease. Previous studies demonstrated that this drug could also inhibit Kaposi’s sarcoma-associated herpesv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Maggie, Smith, Barbara, Jaeyeun, Lee, Petr, Jennifer, Wiseman, Robyn, Anders, Nicole, Rudek, Michelle, Ambinder, Richard, Desai, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659537/
https://www.ncbi.nlm.nih.gov/pubmed/37986957
http://dx.doi.org/10.21203/rs.3.rs-3552962/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659537/
https://www.ncbi.nlm.nih.gov/pubmed/37986957
http://dx.doi.org/10.21203/rs.3.rs-3552962/v1

Ejemplares similares